Back to Authors

Goyal, Sunita

Mayo Clinic

Alnylam Pharmaceuticals (United States)

Citations 1

Evaluation of Quality of Life and Disability in Patients with Hereditary Transthyretin-Mediated (hATTR) Amyloidosis with Polyneuropathy Following Treatment with Patisiran, An Investigational RNAi Therapeutic: Results from the Phase 3 APOLLO Study (S31.003)
O’Riordan, William, Yamashita, Taro , Kristen, Arnt V. , Tournev, Ivaylo, Coelho, Teresa , Lin, Kong-Ping, Dyck, P. James B. , Gandhi, Pritesh J., Sweetser, Marianne T., Goyal, Sunita , Gollob, Jared , Adams, David , González-Duarte, Alejandra , Yang, Chih‐Chao , Schmidt, Hartmut , Berk, John L. , Chen, Jihong , Goyal, Sunita, Suhr, Ole B.

Neurology | December 7, 2023 | Volume: 90 | Issue: 15_supplement | Pages: No page available

10.1212/wnl.90.15_supplement.s31.003 Get It